HEADER IMMUNE SYSTEM 15-SEP-13 4MQ7 TITLE STRUCTURE OF HUMAN CD1D-SULFATIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIGEN-PRESENTING GLYCOPROTEIN CD1D, CD1D1 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HUMAN CD1D ALPHA1,2 DOMAINS FUSED WITH MURINE ALPHA3 COMPND 5 DOMAIN; COMPND 6 SYNONYM: R3G1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: BETA-2-MICROGLOBULIN; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HUMAN, MOUSE; SOURCE 4 ORGANISM_TAXID: 9606, 10090; SOURCE 5 GENE: CD1D, CD1.2, CD1D1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: MOUSE; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 GENE: B2M; SOURCE 14 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS GAMMA-DELTA, T CELL RECEPTOR, HUMANS, T CELLS, NON-CLASSICAL, LIPIDS, KEYWDS 2 CD1D, RESTRICTION, IMMUNOGLOBULIN, MAJOR HISTOCOMPATIBILITY COMPLEX, KEYWDS 3 ANTIGEN PRESENTATION, SELF-LIGANDS, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.M.LUOMA,E.J.ADAMS REVDAT 7 30-OCT-24 4MQ7 1 REMARK REVDAT 6 20-SEP-23 4MQ7 1 HETSYN REVDAT 5 29-JUL-20 4MQ7 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 15-NOV-17 4MQ7 1 REMARK REVDAT 3 02-AUG-17 4MQ7 1 SOURCE REVDAT 2 01-JAN-14 4MQ7 1 JRNL REVDAT 1 18-DEC-13 4MQ7 0 JRNL AUTH A.M.LUOMA,C.D.CASTRO,T.MAYASSI,L.A.BEMBINSTER,L.BAI, JRNL AUTH 2 D.PICARD,B.ANDERSON,L.SCHARF,J.E.KUNG,L.V.SIBENER, JRNL AUTH 3 P.B.SAVAGE,B.JABRI,A.BENDELAC,E.J.ADAMS JRNL TITL CRYSTAL STRUCTURE OF V DELTA 1 T CELL RECEPTOR IN COMPLEX JRNL TITL 2 WITH CD1D-SULFATIDE SHOWS MHC-LIKE RECOGNITION OF A JRNL TITL 3 SELF-LIPID BY HUMAN GAMMA DELTA T CELLS. JRNL REF IMMUNITY V. 39 1032 2013 JRNL REFN ISSN 1074-7613 JRNL PMID 24239091 JRNL DOI 10.1016/J.IMMUNI.2013.11.001 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 14037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.8770 - 4.4493 1.00 2905 136 0.2066 0.2522 REMARK 3 2 4.4493 - 3.5324 1.00 2761 138 0.1940 0.2721 REMARK 3 3 3.5324 - 3.0862 0.99 2694 133 0.2283 0.2697 REMARK 3 4 3.0862 - 2.8041 0.98 2622 153 0.2680 0.3502 REMARK 3 5 2.8041 - 2.6032 0.89 2355 140 0.2957 0.3695 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.590 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3087 REMARK 3 ANGLE : 0.658 4194 REMARK 3 CHIRALITY : 0.041 448 REMARK 3 PLANARITY : 0.003 531 REMARK 3 DIHEDRAL : 11.495 1109 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MQ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1000082228. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03316 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14040 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1ZT4 AND 3GMR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEG 4000, 0.2 M CACL2, 0.1 M TRIS REMARK 280 PH 9.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.78800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 105.47350 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 25.78800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 105.47350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 0 REMARK 465 ASP A 1 REMARK 465 PRO A 2 REMARK 465 VAL A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 PRO A 106 REMARK 465 GLY A 107 REMARK 465 ASN A 108 REMARK 465 ALA A 109 REMARK 465 SER A 110 REMARK 465 GLY A 279 REMARK 465 ARG A 280 REMARK 465 MET B 99 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 6 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 7 CG CD1 CD2 REMARK 470 ARG A 89 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 135 CG CD OE1 NE2 REMARK 470 GLU A 136 CG CD OE1 OE2 REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 GLN A 168 CG CD OE1 NE2 REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 LYS A 178 CG CD CE NZ REMARK 470 LYS A 182 CG CD CE NZ REMARK 470 HIS A 199 CG ND1 CD2 CE1 NE2 REMARK 470 ILE B 1 CG1 CG2 CD1 REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 SER B 57 OG REMARK 470 LYS B 58 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 57 -162.94 -71.92 REMARK 500 TRP B 60 11.58 -65.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MNG RELATED DB: PDB REMARK 900 COMPLEX STRUCTURE OF DP10.7 TCR WITH CD1D-SULFATIDE REMARK 900 RELATED ID: 4MNH RELATED DB: PDB REMARK 900 STRUCTURE OF UNLIGANDED DP10.7 TCR DBREF 4MQ7 A 3 184 UNP P15813 CD1D_HUMAN 21 202 DBREF 4MQ7 A 185 277 UNP Q7TMK5 Q7TMK5_MOUSE 74 166 DBREF 4MQ7 B 1 99 UNP P01887 B2MG_MOUSE 21 119 SEQADV 4MQ7 ALA A 0 UNP P15813 EXPRESSION TAG SEQADV 4MQ7 ASP A 1 UNP P15813 EXPRESSION TAG SEQADV 4MQ7 PRO A 2 UNP P15813 EXPRESSION TAG SEQADV 4MQ7 SER A 278 UNP Q7TMK5 EXPRESSION TAG SEQADV 4MQ7 GLY A 279 UNP Q7TMK5 EXPRESSION TAG SEQADV 4MQ7 ARG A 280 UNP Q7TMK5 EXPRESSION TAG SEQRES 1 A 281 ALA ASP PRO VAL PRO GLN ARG LEU PHE PRO LEU ARG CYS SEQRES 2 A 281 LEU GLN ILE SER SER PHE ALA ASN SER SER TRP THR ARG SEQRES 3 A 281 THR ASP GLY LEU ALA TRP LEU GLY GLU LEU GLN THR HIS SEQRES 4 A 281 SER TRP SER ASN ASP SER ASP THR VAL ARG SER LEU LYS SEQRES 5 A 281 PRO TRP SER GLN GLY THR PHE SER ASP GLN GLN TRP GLU SEQRES 6 A 281 THR LEU GLN HIS ILE PHE ARG VAL TYR ARG SER SER PHE SEQRES 7 A 281 THR ARG ASP VAL LYS GLU PHE ALA LYS MET LEU ARG LEU SEQRES 8 A 281 SER TYR PRO LEU GLU LEU GLN VAL SER ALA GLY CYS GLU SEQRES 9 A 281 VAL HIS PRO GLY ASN ALA SER ASN ASN PHE PHE HIS VAL SEQRES 10 A 281 ALA PHE GLN GLY LYS ASP ILE LEU SER PHE GLN GLY THR SEQRES 11 A 281 SER TRP GLU PRO THR GLN GLU ALA PRO LEU TRP VAL ASN SEQRES 12 A 281 LEU ALA ILE GLN VAL LEU ASN GLN ASP LYS TRP THR ARG SEQRES 13 A 281 GLU THR VAL GLN TRP LEU LEU ASN GLY THR CYS PRO GLN SEQRES 14 A 281 PHE VAL SER GLY LEU LEU GLU SER GLY LYS SER GLU LEU SEQRES 15 A 281 LYS LYS GLN GLU LYS PRO VAL ALA TRP LEU SER SER VAL SEQRES 16 A 281 PRO SER SER ALA HIS GLY HIS ARG GLN LEU VAL CYS HIS SEQRES 17 A 281 VAL SER GLY PHE TYR PRO LYS PRO VAL TRP VAL MET TRP SEQRES 18 A 281 MET ARG GLY ASP GLN GLU GLN GLN GLY THR HIS ARG GLY SEQRES 19 A 281 ASP PHE LEU PRO ASN ALA ASP GLU THR TRP TYR LEU GLN SEQRES 20 A 281 ALA THR LEU ASP VAL GLU ALA GLY GLU GLU ALA GLY LEU SEQRES 21 A 281 ALA CYS ARG VAL LYS HIS SER SER LEU GLY GLY GLN ASP SEQRES 22 A 281 ILE ILE LEU TYR TRP SER GLY ARG SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 B 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 B 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS ALA SER MET ALA GLU PRO LYS SEQRES 8 B 99 THR VAL TYR TRP ASP ARG ASP MET MODRES 4MQ7 ASN A 42 ASN GLYCOSYLATION SITE HET NAG A 301 14 HET CIS A 302 61 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CIS (15Z)-N-((1S,2R,3E)-2-HYDROXY-1-{[(3-O-SULFO-BETA-D- HETNAM 2 CIS GALACTOPYRANOSYL)OXY]METHYL}HEPTADEC-3-ENYL)TETRACOS- HETNAM 3 CIS 15-ENAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN CIS (2S,3R,4E)-N-NERVONIC-1-[BETA-D-(3-SULFATE)- HETSYN 2 CIS GALACTOPYRANOSYL]-2-AMINO-OCTADECENE-3-OL; CIS- HETSYN 3 CIS TETRACOSENOYL SULFATIDE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 CIS C48 H91 N O11 S FORMUL 5 HOH *85(H2 O) HELIX 1 1 SER A 59 LEU A 88 1 30 HELIX 2 2 LEU A 139 ASN A 149 1 11 HELIX 3 3 ASP A 151 GLY A 164 1 14 HELIX 4 4 GLY A 164 GLY A 177 1 14 HELIX 5 5 GLY A 177 LYS A 182 1 6 HELIX 6 6 HIS A 265 GLY A 269 5 5 SHEET 1 A 8 ARG A 48 SER A 49 0 SHEET 2 A 8 LEU A 35 TRP A 40 -1 N SER A 39 O ARG A 48 SHEET 3 A 8 THR A 24 LEU A 32 -1 N GLY A 28 O TRP A 40 SHEET 4 A 8 LEU A 10 PHE A 18 -1 N ILE A 15 O ASP A 27 SHEET 5 A 8 LEU A 94 CYS A 102 -1 O ALA A 100 N CYS A 12 SHEET 6 A 8 ASN A 112 PHE A 118 -1 O HIS A 115 N SER A 99 SHEET 7 A 8 LYS A 121 GLN A 127 -1 O LYS A 121 N PHE A 118 SHEET 8 A 8 SER A 130 PRO A 133 -1 O GLU A 132 N SER A 125 SHEET 1 B 4 VAL A 188 PRO A 195 0 SHEET 2 B 4 HIS A 201 PHE A 211 -1 O VAL A 205 N SER A 192 SHEET 3 B 4 TRP A 243 GLU A 252 -1 O VAL A 251 N ARG A 202 SHEET 4 B 4 HIS A 231 ARG A 232 -1 N HIS A 231 O THR A 248 SHEET 1 C 4 VAL A 188 PRO A 195 0 SHEET 2 C 4 HIS A 201 PHE A 211 -1 O VAL A 205 N SER A 192 SHEET 3 C 4 TRP A 243 GLU A 252 -1 O VAL A 251 N ARG A 202 SHEET 4 C 4 LEU A 236 PRO A 237 -1 N LEU A 236 O TYR A 244 SHEET 1 D 4 GLN A 225 GLU A 226 0 SHEET 2 D 4 TRP A 217 ARG A 222 -1 N ARG A 222 O GLN A 225 SHEET 3 D 4 LEU A 259 LYS A 264 -1 O ALA A 260 N MET A 221 SHEET 4 D 4 ILE A 273 TYR A 276 -1 O ILE A 273 N VAL A 263 SHEET 1 E 4 GLN B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 E 4 GLU B 50 MET B 51 -1 N GLU B 50 O HIS B 67 SHEET 1 F 4 GLN B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 LYS B 44 LYS B 45 0 SHEET 2 G 4 ILE B 35 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 G 4 TYR B 78 HIS B 84 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 TYR B 94 -1 O VAL B 93 N CYS B 80 SSBOND 1 CYS A 102 CYS A 166 1555 1555 2.03 SSBOND 2 CYS A 206 CYS A 261 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 LINK ND2 ASN A 42 C1 NAG A 301 1555 1555 1.44 CISPEP 1 TYR A 92 PRO A 93 0 3.69 CISPEP 2 TYR A 212 PRO A 213 0 3.32 CISPEP 3 HIS B 31 PRO B 32 0 4.38 CRYST1 40.959 51.576 210.947 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024415 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019389 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004741 0.00000